Advertisement

Topics

Combination therapy strengthens T cells in melanoma pre-clinical study

20:00 EDT 16 Apr 2018 | AAAS

(University of Texas M. D. Anderson Cancer Center) A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system's ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN. The study was led by investigators at The University of Texas MD Anderson Cancer Center.

Original Article: Combination therapy strengthens T cells in melanoma pre-clinical study

NEXT ARTICLE

More From BioPortfolio on "Combination therapy strengthens T cells in melanoma pre-clinical study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....